Floatz logo

889 assets in Neoplasm

Therapeutic assets addressing Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Incb186748
Neoplasm
Incyte CorporationP1C (37)
Infusion Of 4H11-28Z/Fil-12/Egfrt+ Genetically-Modified T Cells
Neoplasm
Memorial Sloan Kettering Cancer CenterP1C (37)
Intismeran Autogene
Neoplasm
ModernaTX, Inc.P1C (37)
Jnj-1761981
Neoplasm
Johnson & Johnson Enterprise Innovation Inc.P1C (37)
Jnj-54179060
Neoplasm
Janssen Research & Development, LLCP1C (37)
Jnj-64264681
Neoplasm
Janssen Research & Development, LLCP1C (37)
Jnj-74856665
Neoplasm
Janssen Research & Development, LLCP1C (37)
Jnj-80948543
Neoplasm
Janssen Research & Development, LLCP1C (37)
Jnj-87704916
Neoplasm
Johnson & Johnson Enterprise Innovation Inc.P1C (37)
Jnj-87801493
Neoplasm
Janssen Research & Development, LLCP1C (37)
Jnj-87890387
Neoplasm
Janssen Research & Development, LLCP1C (37)
jr8603
Neoplasm
JiaRay GroupP1C (37)
jv-394
Neoplasm
M.D. Anderson Cancer CenterP1C (37)
ky-0118
Neoplasm
Novatim Immune Therapeutics (Zhejiang) Co., Ltd.P1C (37)
Lutetium [177Lu] Bl-Arc001
Neoplasm
Sichuan Baili Pharmaceutical Co., Ltd.P1C (37)
Mdc-Car-Bcma001
Neoplasm
Technische Universität DresdenP1C (37)
Pebezertinib
Neoplasm
Blueprint Medicines CorporationP1C (37)
pep08
Neoplasm
PharmaEngineP1C (37)
pf-07224826
Neoplasm
PfizerP1C (37)
pf-07820435
Neoplasm
PfizerP1C (37)
pf-07826390
Neoplasm
PfizerP1C (37)
pf-08046031
Neoplasm
PfizerP1C (37)
Pimicotinib
Neoplasm
Abbisko Therapeutics Co, LtdP1C (37)
qls5316
Neoplasm
Qilu Pharmaceutical Co., Ltd.P1C (37)
qtx3034
Neoplasm
Quanta TherapeuticsP1C (37)
Remzistotug
Neoplasm
GlaxoSmithKlineP1C (37)
ro7444973
Neoplasm
Hoffmann-La RocheP1C (37)
ro7673396
Neoplasm
Hoffmann-La RocheP1C (37)
Runimotamab
Neoplasm
Genentech, Inc.P1C (37)
Safimaltib
Neoplasm
Janssen Research & Development, LLCP1C (37)
syh2051
Neoplasm
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.P1C (37)
sys6005
Neoplasm
CSPC Megalith Biopharmaceutical Co.,Ltd.P1C (37)
Tak-103
Neoplasm
TakedaP1C (37)
Tarlatamab
Neoplasm
GlaxoSmithKlineP1C (37)
Tnhyp217 Car T Cells
Neoplasm
National Cancer Institute (NCI)P1C (37)
Trop2-Car-Nk Cells
Neoplasm
M.D. Anderson Cancer CenterP1C (37)
TX103 CAR-T
Neoplasm
Tcelltech Inc.P1C (37)
Tyra-430
Neoplasm
Tyra Biosciences, IncP1C (37)
Val-413
Neoplasm
Valent Technologies, LLCP1C (37)
Vrp-Encapsulated Sarna Encoding Il-12
Neoplasm
VLP TherapeuticsP1C (37)
xb371
Neoplasm
ExelixisP1C (37)
Xmab662
Neoplasm
Xencor, Inc.P1C (37)
Zimberelimab
Neoplasm
Compugen LtdP1C (37)
zl-6201
Neoplasm
Zai Lab (Shanghai) Co., Ltd.P1C (37)
11C-YJH08
Neoplasm
Rahul AggarwalP1C (36)
1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10-TETRAMETHYLENEPHOSPHONIC ACID
Neoplasm
QSAM Therapeutics, Inc.P1C (36)
18f-trx
Neoplasm
Rahul AggarwalP1C (36)
68Ga-NODAGA-SNA006
Neoplasm
SmartNuclide BiopharmaEarly P1C (36)
89-zr-dfo-star polyethylene glycol
Neoplasm
Robert Flavell, MD, PhDP1C (36)
Absk121-Nx
Neoplasm
Abbisko Therapeutics Co, LtdP1C (36)
Showing 601 to 650 of 889 assets
PreviousPage 13 of 18Next